Bill Text: CA SB609 | 2015-2016 | Regular Session | Amended

California Senate Bill 609 (Prior Session Legislation)

Bill Title: Controlled substances: narcotic replacement treatment.

Sponsorship: Partisan Bill (Republican 1)

Status: (Failed) 2016-02-01 - Returned to Secretary of Senate pursuant to Joint Rule 56. [SB609 Detail]

Download: California-2015-SB609-Amended.html

BILL NUMBER: SB 609	AMENDED
	BILL TEXT

	AMENDED IN SENATE  APRIL 21, 2015

INTRODUCED BY   Senator Stone

                        FEBRUARY 27, 2015

   An act to amend Section  120100   11839.2
 of the Health and Safety Code, relating to 
communicable disease.   controlled substances. 


	LEGISLATIVE COUNSEL'S DIGEST


   SB 609, as amended, Stone.  Communicable disease:
prevention and control.   Controlled substances:
narcotic replacement treatment.  
   Existing law specifies the controlled substances that may be used
in narcotic replacement therapy by licensed narcotic treatment
programs, including federally approved controlled substances used for
the purpose of narcotic replacement treatment, and requires the
State Department of Public Health to establish guidelines for
narcotic treatment programs, including dosage requirements. 

   This bill would, instead, authorize the use of federally approved
controlled substances used for the purpose of substance use disorder
treatment.  
   Existing law, the Communicable Disease Prevention and Control Act,
imposes various functions and duties on the State Department of
Public Health and local health officers with respect to the
prevention and control of communicable diseases. The act provides
that a health officer includes county, city, and district health
officers, and city and district health boards, but not advisory
health boards.  
   This bill would make a technical, nonsubstantive change to this
provision. 
   Vote: majority. Appropriation: no. Fiscal committee:  no
  yes  . State-mandated local program: no.


THE PEOPLE OF THE STATE OF CALIFORNIA DO ENACT AS FOLLOWS:

   SECTION 1.    Section 11839.2 of the  
Health and Safety Code   is amended to read: 
   11839.2.  The following controlled substances are authorized for
use in narcotic replacement therapy by licensed narcotic treatment
programs:
   (a) Methadone.
   (b) Levoalphacetylmethadol (LAAM) as specified in paragraph (10)
of subdivision (c) of Section 11055.
   (c) Buprenorphine products or combination of products approved by
the federal Food and Drug Administration for maintenance or
detoxification of opioid dependence.
   (d) Any other federally  approved,   approved
 controlled substances used for the purpose of 
narcotic replacement   substance use disorder 
treatment. 
  SECTION 1.    Section 120100 of the Health and
Safety Code is amended to read:
   120100.  "Health officer," as used in the Communicable Disease
Prevention and Control Act as set forth in Section 27, includes
county, city, and district health officers, and city and district
health boards, but does not include advisory health boards.